HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amy E Wright Selected Research

Cytokines

1/2024Anti-aquaporin-4 immune complex stimulates complement-dependent Th17 cytokine release in neuromyelitis optica spectrum disorders.
2/2015The marine natural product microsclerodermin A is a novel inhibitor of the nuclear factor kappa B and induces apoptosis in pancreatic cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Amy E Wright Research Topics

Disease

17Neoplasms (Cancer)
01/2021 - 07/2003
10Pancreatic Neoplasms (Pancreatic Cancer)
01/2017 - 02/2009
2Neuromyelitis Optica (Devic's Disease)
01/2024 - 12/2022
2Inflammation (Inflammations)
01/2024 - 02/2015
2Colonic Neoplasms (Colon Cancer)
01/2021 - 11/2016
2Adenocarcinoma
01/2017 - 01/2017
1Autoimmune Diseases of the Nervous System
03/2024
1Central Nervous System Diseases (CNS Diseases)
03/2024
1Autoimmune Diseases (Autoimmune Disease)
03/2024
1Triple Negative Breast Neoplasms
12/2023
1Hemolysis
11/2023
1Malaria
03/2021
1Disease Progression
01/2021
1Carcinoma (Carcinomatosis)
01/2021
1Tuberculosis (Tuberculoses)
01/2017
1Sarcoma (Soft Tissue Sarcoma)
03/2007
1Leukemia
03/2007
1Adenocarcinoma of Lung
03/2007

Drug/Important Bio-Agent (IBA)

8Paclitaxel (Taxol)FDA LinkGeneric
02/2011 - 07/2003
5dictyostatinIBA
01/2010 - 05/2007
4MacrolidesIBA
01/2017 - 12/2008
3discodermolideIBA
01/2010 - 05/2007
2AntigensIBA
03/2024 - 01/2024
2Complement System Proteins (Complement)IBA
01/2024 - 12/2022
2CytokinesIBA
01/2024 - 02/2015
2manzamine AIBA
09/2013 - 10/2011
2AldehydesIBA
03/2009 - 12/2008
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
03/2009 - 07/2003
1poly(lactide) (polylactic acid)IBA
03/2024
1Myelin-Oligodendrocyte GlycoproteinIBA
03/2024
1glycolic acid (glycolate)IBA
03/2024
1Interleukin-6 (Interleukin 6)IBA
01/2024
1Antigen-Antibody Complex (Immune Complex)IBA
01/2024
1InterleukinsIBA
01/2024
1Interleukin-17 (Interleukin 17)IBA
01/2024
1dragmacidin DIBA
12/2023
1Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
11/2023
1Complement Receptors (Complement Receptor)IBA
12/2022
1IgG Receptors (Fc gamma RI)IBA
12/2022
1eculizumabFDA Link
12/2022
1SurvivinIBA
01/2021
1dragmacidin GIBA
01/2017
1Interleukin-8 (Interleukin 8)IBA
01/2017
1theopederin KIBA
01/2017
1leiodermatolide CIBA
01/2017
1didemninsIBA
01/2017
1EnzymesIBA
01/2017
1ImmunosorbentsIBA
01/2017
1LuciferasesIBA
01/2017
1nordidemnin BIBA
01/2017
1Antimitotic AgentsIBA
11/2016
1leiodermatolideIBA
11/2016
1GemcitabineFDA Link
11/2016
1PolyketidesIBA
11/2016
1Transcription Factors (Transcription Factor)IBA
02/2015
1Apoptosis Regulatory ProteinsIBA
02/2015
1NF-kappa B (NF-kB)IBA
02/2015
1microsclerodermin AIBA
02/2015
1Caspase 3 (Caspase-3)IBA
09/2014
1Proteins (Proteins, Gene)FDA Link
09/2014
1Adenosine Triphosphatases (ATPase)IBA
09/2013
1Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA
09/2013
1neopetrosiquinone AIBA
11/2011
1Docetaxel (Taxotere)FDA Link
01/2010
1lasonolide AIBA
11/2009
1aphrocallistinIBA
06/2009
1beta-ketophosphonateIBA
12/2008
110,11-dihydrodictyostatinIBA
03/2008
1neopeltolideIBA
03/2007
1Cytotoxins (Cytolysins)IBA
07/2003

Therapy/Procedure

3Therapeutics
03/2021 - 02/2009
1Immunotherapy
01/2019
1Drug Therapy (Chemotherapy)
02/2015